Literature DB >> 8762106

Desensitization of glucagon-like peptide 1 receptors in insulin-secreting beta TC3 cells: role of PKA-independent mechanisms.

J Gromada1, S Dissing, P Rorsman.   

Abstract

1. The cellular processes involved in the desensitization of the glucagon-like peptide 1 receptors were investigated by measurements of the glucagon-like peptide 1(7-36)amide (GLP-1(7-36)amide)-induced increases in intracellular free Ca2+ concentration ([Ca2+]i) in insulin-secreting beta TC3 cells. 2. In the presence of 11.2 mM glucose, stimulation with GLP-1(7-36)amide led to a small membrane depolarization (< 10 mV), induction of electrical activity and a rapid increase in [Ca2+]i. The increase in [Ca2+]i was not observed in the presence of the L-type Ca(2+)-channel antagonist nifedipine. However, nifedipine was ineffective when applied after addition of GLP-1(7-36)amide. 3. The increase in [Ca2+]i evoked by GLP-1-(7-36)amide was transient and even in the continued presence of the agonist, [Ca2+]i returned to the basal value within 4-5 min. The latter process was slowed, but not prevented, by inhibition of protein kinase C (PKC) by staurosporine and Ro31-8220. 4. Short pretreatment of the cells with the phorbol ester, 4-beta-phorbol-12-beta-myristate-13-alpha-acetate (PMA), an activator of PKC, reduced the GLP-1(7-36)amide-evoked increase in [Ca2+]i by 75%. This effect of PMA was fully reversed by staurosporine and Ro31-8220. 5. The ability of GLP-1(7-36)amide to increase [Ca2+]i disappeared upon pre-exposure of the cells to the hormone (desensitization). This process was maximal within 5 min of exposure to the agonist. Following removal of the agonist from the medium, the ability to respond to subsequent stimulation by GLP-1(7-36)amide recovered gradually with time; half and complete recovery requiring > 20 min and 60 min, respectively. The desensitizing action of GLP-1(7-36)amide persisted in the presence of either staurosporine or forskolin and did not require an elevation of [Ca2+]i. 6. Our data suggest that the GLP-1(7-36)amide-evoked increase in [Ca2+]i is initiated by Ca(2+)-influx though voltage-dependent and nifedipine-sensitive L-type Ca2+ channels but depends principally on Ca2+ mobilization from internal stores for its maintenance. The desensitization of the GLP-1 receptors that occurs in the continued presence of the agonist does not result from the activation of protein kinase A or Ca(2+)-dependent kinases/phosphatases. Our data indicate that activation of PKC may contribute to the desensitization of the GLP-1 receptors but that other (PKC-independent) mechanisms also participate in this process.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8762106      PMCID: PMC1909716          DOI: 10.1111/j.1476-5381.1996.tb15466.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  31 in total

1.  Activation of protein kinase C assists insulin producing cells in recovery from raised cytoplasmic Ca2+ by stimulating Ca2+ efflux.

Authors:  P O Berggren; P Arkhammar; T Nilsson
Journal:  Biochem Biophys Res Commun       Date:  1989-11-30       Impact factor: 3.575

2.  Phosphorylation/dephosphorylation of the beta-adrenergic receptor regulates its functional coupling to adenylate cyclase and subcellular distribution.

Authors:  D R Sibley; R H Strasser; J L Benovic; K Daniel; R J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

3.  A new generation of Ca2+ indicators with greatly improved fluorescence properties.

Authors:  G Grynkiewicz; M Poenie; R Y Tsien
Journal:  J Biol Chem       Date:  1985-03-25       Impact factor: 5.157

4.  Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line.

Authors:  D J Drucker; J Philippe; S Mojsov; W L Chick; J F Habener
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

5.  Glucagon-like peptide-I analogs: effects on insulin secretion and adenosine 3',5'-monophosphate formation.

Authors:  D Gefel; G K Hendrick; S Mojsov; J Habener; G C Weir
Journal:  Endocrinology       Date:  1990-04       Impact factor: 4.736

6.  Beta-cell lines derived from transgenic mice expressing a hybrid insulin gene-oncogene.

Authors:  S Efrat; S Linde; H Kofod; D Spector; M Delannoy; S Grant; D Hanahan; S Baekkeskov
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

7.  Somatostatin induces translocation of the beta-adrenergic receptor kinase and desensitizes somatostatin receptors in S49 lymphoma cells.

Authors:  F Mayor; J L Benovic; M G Caron; R J Lefkowitz
Journal:  J Biol Chem       Date:  1987-05-15       Impact factor: 5.157

8.  Stimulation of cloned human glucagon-like peptide 1 receptor expressed in HEK 293 cells induces cAMP-dependent activation of calcium-induced calcium release.

Authors:  J Gromada; P Rorsman; S Dissing; B S Wulff
Journal:  FEBS Lett       Date:  1995-10-09       Impact factor: 4.124

9.  Receptors for glucagon-like peptide-1(7-36) amide on rat insulinoma-derived cells.

Authors:  R Göke; J M Conlon
Journal:  J Endocrinol       Date:  1988-03       Impact factor: 4.286

10.  Comparison of the effects of various C-terminal and N-terminal fragment peptides of glucagon-like peptide-1 on insulin and glucagon release from the isolated perfused rat pancreas.

Authors:  S Suzuki; K Kawai; S Ohashi; H Mukai; K Yamashita
Journal:  Endocrinology       Date:  1989-12       Impact factor: 4.736

View more
  9 in total

Review 1.  Glucagon-like peptide 1 (GLP-1).

Authors:  T D Müller; B Finan; S R Bloom; D D'Alessio; D J Drucker; P R Flatt; A Fritsche; F Gribble; H J Grill; J F Habener; J J Holst; W Langhans; J J Meier; M A Nauck; D Perez-Tilve; A Pocai; F Reimann; D A Sandoval; T W Schwartz; R J Seeley; K Stemmer; M Tang-Christensen; S C Woods; R D DiMarchi; M H Tschöp
Journal:  Mol Metab       Date:  2019-09-30       Impact factor: 7.422

Review 2.  Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes.

Authors:  Chris de Graaf; Dan Donnelly; Denise Wootten; Jesper Lau; Patrick M Sexton; Laurence J Miller; Jung-Mo Ahn; Jiayu Liao; Madeleine M Fletcher; Dehua Yang; Alastair J H Brown; Caihong Zhou; Jiejie Deng; Ming-Wei Wang
Journal:  Pharmacol Rev       Date:  2016-10       Impact factor: 25.468

Review 3.  A role of PLC/PKC-dependent pathway in GLP-1-stimulated insulin secretion.

Authors:  Makoto Shigeto; Chae Young Cha; Patrik Rorsman; Kohei Kaku
Journal:  J Mol Med (Berl)       Date:  2017-01-17       Impact factor: 4.599

4.  SUMO downregulates GLP-1-stimulated cAMP generation and insulin secretion.

Authors:  Sindhu Rajan; Jacqueline Torres; Michael S Thompson; Louis H Philipson
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-01-10       Impact factor: 4.310

5.  cAMP-dependent mobilization of intracellular Ca2+ stores by activation of ryanodine receptors in pancreatic beta-cells. A Ca2+ signaling system stimulated by the insulinotropic hormone glucagon-like peptide-1-(7-37).

Authors:  G G Holz; C A Leech; R S Heller; M Castonguay; J F Habener
Journal:  J Biol Chem       Date:  1999-05-14       Impact factor: 5.157

Review 6.  Plasticity of the beta cell insulin secretory competence: preparing the pancreatic beta cell for the next meal.

Authors:  Simon A Hinke; Karine Hellemans; Frans C Schuit
Journal:  J Physiol       Date:  2004-06-04       Impact factor: 5.182

7.  Lipid raft-dependent glucagon-like peptide-2 receptor trafficking occurs independently of agonist-induced desensitization.

Authors:  Jennifer L Estall; Bernardo Yusta; Daniel J Drucker
Journal:  Mol Biol Cell       Date:  2004-05-28       Impact factor: 4.138

8.  Chronic hyperglycemia downregulates GLP-1 receptor signaling in pancreatic β-cells via protein kinase A.

Authors:  Sindhu Rajan; Lorna M Dickson; Elizabeth Mathew; Caitlin M O Orr; Johanne H Ellenbroek; Louis H Philipson; Barton Wicksteed
Journal:  Mol Metab       Date:  2015-02-03       Impact factor: 7.422

9.  Glucagon-like peptide 1 recruits muscle microvasculature and improves insulin's metabolic action in the presence of insulin resistance.

Authors:  Weidong Chai; Xingxing Zhang; Eugene J Barrett; Zhenqi Liu
Journal:  Diabetes       Date:  2014-03-21       Impact factor: 9.461

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.